Privacy PolicyTerms of Service
OslerMarket
K
Ask OslerLibraryLearn
OslerMarket

Filtered resources

Clinical library

444 resources

Explore a topic. Choose a collection. Find your next resource.

444 resources
Clear filters

Collections 3

Cardiology: ACS & Heart Failure16 resourcesHypertension9 resourcesECG & More17 resources

Collections

3 of 45
  • Cardiology: ACS & Heart Failure16 resourcesACS by Labu Albert · MANAGEMENT OF ACUTE CORONARY SYNDROME …
  • Hypertension9 resources2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults · ESC 2024 Hypertension Guidelines …
  • ECG & More17 resourcesAN INTRODUCTION TO THE ECG and arrythmias revision ECG Oct 2025 (2) · LITTLE BLACK BOOK OF ECG SECRETS …

Resources

24 shown
NICE NAMES PHARMACISTS AS PART OF HEART FAILURE MULTIDISCIPLINARY TEAM FOR FIRST TIME coverClinical reviewsNICE NAMES PHARMACISTS AS PART OF HEART FAILURE MULTIDISCIPLINARY TEAM FOR FIRST TIMEPharmaceutical Journal·Cardiology· 2025· 4 pagesThe National Institute for Health and Care Excellence’s updated guidance for chronic heart failure has introduced pharmacists as part of the multidisciplinary team for the first time, enabling them to take on more management of the condition.
LONG QT SYNDROME coverClinical reviewsLONG QT SYNDROMEPeter J. Schwartz, M.D., Lia Crotti, M.D., Ph.D.·Cardiology· 12 pagesThis review article discusses Long QT Syndrome, a genetic condition characterized by prolonged QT intervals on ECG and a risk of life-threatening arrhythmias. It emphasizes the importance of timely diagnosis and appropriate management to prevent sudden cardiac death.
EUROPEAN SOCIETY OF HYPERTENSION PRACTICE GUIDELINES FOR AMBULATORY BLOOD PRESSURE MONITORING coverGuidelines & protocolsEUROPEAN SOCIETY OF HYPERTENSION PRACTICE GUIDELINES FOR AMBULATORY BLOOD PRESSURE MONITORINGEuropean Society of Hypertension·Cardiology· 8 pagesThis document provides updated recommendations for the use of ambulatory blood pressure monitoring (ABPM) in clinical practice, addressing methodological issues and clinical indications.
NOT ALL HOSPITALIZED HEART FAILURE PATIENTS ARE THE SAME coverClinical reviewsNOT ALL HOSPITALIZED HEART FAILURE PATIENTS ARE THE SAMEGarrick C. Stewart, MD, MPH·Cardiology· 5 pagesThis document discusses the heterogeneity of hospitalized heart failure patients and the implications for treatment and outcomes. It highlights the increasing prevalence of heart failure and the challenges associated with hospitalizations.
WHAT IS A CARDIAC CT CALCIUM SCORE? coverClinical reviewsWHAT IS A CARDIAC CT CALCIUM SCORE?JAMA·Cardiology· 2025· 1 pagesThis document explains the significance of a cardiac CT calcium score in assessing the presence of calcium in the coronary arteries, which can indicate the risk of heart disease.
UTILITY OF INTRACARDIAC ECHOCARDIOGRAPHY FOR INFECTIVE ENDOCARDITIS AND CARDIOVASCULAR DEVICE-RELATED ENDOCARDITIS: A CONTEMPORARY SYSTEMATIC REVIEW coverClinical reviewsUTILITY OF INTRACARDIAC ECHOCARDIOGRAPHY FOR INFECTIVE ENDOCARDITIS AND CARDIOVASCULAR DEVICE-RELATED ENDOCARDITIS: A CONTEMPORARY SYSTEMATIC REVIEWCleveland Clinic·Cardiology· 17 pagesThis systematic review evaluates the role of intracardiac echocardiography (ICE) in diagnosing infective endocarditis (IE) and cardiovascular device-related endocarditis (CDIE), particularly in cases where traditional echocardiography methods are inconclusive.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE coverClinical reviewsSURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASEPamela S. Douglas, MD; Amanda Stebbins, MS; Borek Foldyna, MD, PhD; Manesh R. Patel, MD; Daniel B. Mark, MD, MPH; Michael T. Lu, MD, MPH; Udo Hoffmann, MD, MPH; Svati H. Shah, MD, MHS; Beth Martinez, BS; Brooke Alhanti, PhD; Neha Pagidipati, MD, MPH·Cardiology· 5 pagesThis study analyzes long-term outcomes in patients with suspected coronary artery disease who underwent either functional (stress) or anatomic (coronary computed tomographic angiography) testing.
1
NITROGLYCERIN (GLYCERYL TRINITRATE): DRUG INFORMATION coverMedicines & prescribingNITROGLYCERIN (GLYCERYL TRINITRATE): DRUG INFORMATIONUpToDate, Inc.·Cardiology· 2026· 40 pagesThis document provides comprehensive drug information on nitroglycerin, including its pharmacologic category, dosing guidelines, and potential drug interactions.
OPTIMIZATION OF THE ATRIOVENTRICULAR DELAY IN SEQUENTIAL AND BIVENTRICULAR PACING: PHYSIOLOGICAL BASES, CRITICAL REVIEW, AND NEW PURPOSES coverClinical reviewsOPTIMIZATION OF THE ATRIOVENTRICULAR DELAY IN SEQUENTIAL AND BIVENTRICULAR PACING: PHYSIOLOGICAL BASES, CRITICAL REVIEW, AND NEW PURPOSESDepartment of Cardiology, San Filippo Neri Hospital, Rome, Italy·Cardiology· 2012· 10 pagesThis manuscript discusses the optimization of atrioventricular (AV) delay in sequential and biventricular pacing, highlighting the importance of proper settings for successful stimulation. It critically reviews various methods for programming AV delay and suggests new approaches for achieving optimal outcomes.
WHAT'S NEW IN CARDIOVASCULAR MEDICINE coverClinical reviewsWHAT'S NEW IN CARDIOVASCULAR MEDICINENaomi F Botkin, MD, Todd F Dardas, MD, MS, Susan B Yeon, MD, JD·Cardiology· 2026· 15 pagesThis document provides updates on recent advancements and findings in cardiovascular medicine, highlighting significant studies and their implications for clinical practice.
BEDSIDE ULTRASOUND OF THE INTERNAL JUGULAR VEIN TO ASSESS FLUID STATUS AND RIGHT VENTRICULAR FUNCTION: THE POCUS-JVD STUDY coverClinical reviewsBEDSIDE ULTRASOUND OF THE INTERNAL JUGULAR VEIN TO ASSESS FLUID STATUS AND RIGHT VENTRICULAR FUNCTION: THE POCUS-JVD STUDYUniversity of Kentucky, Lexington, KY, United States of America·Cardiology· 2023· 6 pagesThis study investigates the use of bedside ultrasound of the internal jugular vein (IJV) to assess fluid status and right ventricular function in patients with heart failure. It evaluates various ultrasound measurements and their correlation with right atrial pressure.
ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION coverClinical reviewsANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONDominick J. Angiolillo, Deepak L. Bhatt, Christopher P. Cannon, John W. Eikelboom, C. Michael Gibson, Shaun G. Goodman, Christopher B. Granger, David R. Holmes, Renato D. Lopes, Roxana Mehran, David J. Moliterno·Cardiology· 2021· 14 pagesThis document provides an updated perspective on the management of antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI). It highlights the challenges and recommendations for optimal antithrombotic management in this patient population.
HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION: A CALL FOR A PRECISION MEDICINE APPROACH coverClinical reviewsHEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION: A CALL FOR A PRECISION MEDICINE APPROACHAmerican College of Cardiology·Cardiology· 2026· 17 pagesThis document discusses heart failure with mildly reduced ejection fraction (HFmrEF) as a distinct phenotype within the heart failure spectrum, emphasizing the need for precision medicine in its management.
VASOPRESSIN IN CARDIOGENIC SHOCK: PATHOPHYSIOLOGY, CLINICAL EVIDENCE, AND THERAPEUTIC PERSPECTIVES coverClinical reviewsVASOPRESSIN IN CARDIOGENIC SHOCK: PATHOPHYSIOLOGY, CLINICAL EVIDENCE, AND THERAPEUTIC PERSPECTIVESDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS; Berne Cardiovascular Research Center, University of Virginia; Department of Cardiovascular and Respiratory Sciences, Catholic University of the Sacred Heart·Cardiology· 2026· 9 pagesThis review presents a comprehensive synthesis of the pharmacologic mechanisms, haemodynamic effects, and clinical applications of vasopressin in cardiogenic shock. It highlights patient profiles that may benefit from vasopressin and outlines scenarios where its use may be detrimental.
UPDATE ON MANAGEMENT OF HYPOKALEMIA AND GOALS FOR THE LOWER POTASSIUM LEVEL IN PATIENTS WITH CARDIOVASCULAR DISEASE coverClinical reviewsUPDATE ON MANAGEMENT OF HYPOKALEMIA AND GOALS FOR THE LOWER POTASSIUM LEVEL IN PATIENTS WITH CARDIOVASCULAR DISEASEAalborg University Hospital, Copenhagen University Hospital, Lady Davis Carmel Medical Center, University of the Saarland, Bern University Hospital, Desenzano Del Garda Hospital, University of Copenhagen·Cardiology· 11 pagesThis document reviews the management of hypokalaemia and establishes potassium level targets for patients with cardiovascular diseases, in collaboration with the European Society of Cardiology.
DEFINING STRATEGIES OF MODULATION OF ANTIPLATELET THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: A CONSENSUS DOCUMENT FROM THE ACADEMIC RESEARCH CONSORTIUM coverGuidelines & protocolsDEFINING STRATEGIES OF MODULATION OF ANTIPLATELET THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: A CONSENSUS DOCUMENT FROM THE ACADEMIC RESEARCH CONSORTIUMDavide Capodanno, MD, PhD; Roxana Mehran, MD; Mitchell W. Krucoff, MD; Usman Baber, MD; Deepak L. Bhatt, MD, MPH; Piera Capranzano, MD, PhD; Jean-Philippe Collet, MD, PhD; Thomas Cuisset, MD, PhD; Giuseppe De Luca, MD, PhD; Leonardo De Luca, MD, PhD;·Cardiology· 12 pagesThis consensus document outlines strategies for modulating antiplatelet therapy in patients with coronary artery disease, focusing on the prevention of thrombotic or ischemic events. It discusses the use of various antiplatelet agents and their effectiveness in different clinical scenarios.
LOW DOSE RIVAROXABAN FOR THE MANAGEMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE coverClinical reviewsLOW DOSE RIVAROXABAN FOR THE MANAGEMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASEPlacido Maria Mazzone, Davide Capodanno·Cardiology· 2023· 12 pagesThis document discusses the use of low-dose rivaroxaban in managing atherosclerotic cardiovascular disease, highlighting its potential benefits and current guidelines for its use in conjunction with standard therapy.
STRUCTURED REPORTING OF CARDIOVASCULAR MAGNETIC RESONANCE BASED ON EXPERT CONSENSUSES AND GUIDELINES coverClinical reviewsSTRUCTURED REPORTING OF CARDIOVASCULAR MAGNETIC RESONANCE BASED ON EXPERT CONSENSUSES AND GUIDELINESDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, China·Cardiology· 2020· 8 pagesThis article aims to construct a structured cardiac magnetic resonance (CMR) report template suitable for China's actual conditions, addressing the gap in CMR diagnostic report normalization between China and developed countries.
EXERCISE STRESS ECHOCARDIOGRAPHY FOR DIAGNOSIS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION: A MULTICENTRE STUDY coverClinical reviewsEXERCISE STRESS ECHOCARDIOGRAPHY FOR DIAGNOSIS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION: A MULTICENTRE STUDYMayo Clinic, Gunma University Graduate School of Medicine, University Hospital Brussels, Alfred Hospital, Vrije Universiteit Brussel·Cardiology· 2026· 15 pagesThis study evaluates the effectiveness of exercise stress echocardiography as a non-invasive alternative for diagnosing heart failure with preserved ejection fraction (HFpEF). It aims to provide an evidence-based operational framework for its application.
2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association coverGuidelines & protocols2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart AssociationAmerican Heart Association·Cardiology· 2026· 11 pagesThis document provides evidence-based dietary guidance aimed at improving cardiovascular health and reducing the risk of cardiovascular disease. It outlines key features of heart-healthy dietary patterns and their associated benefits.
1
RIGHT VENTRICULAR DIASTOLIC DYSFUNCTION AND FAILURE: A REVIEW coverClinical reviewsRIGHT VENTRICULAR DIASTOLIC DYSFUNCTION AND FAILURE: A REVIEWYoun‑Hoa Jung, Xianfeng Ren, Giancarlo Suffredini, Jeffery M. Dodd‑o, Wei Dong Gao·Cardiology· 2021· 14 pagesThis review discusses right ventricular diastolic dysfunction and failure (RVDDF), highlighting its significance in cardiovascular diseases and its role as a marker of end-organ dysfunction. The manuscript covers anatomical features, diagnostic challenges, underlying mechanisms, and clinical management of RVDDF.
RISK-BASED PRIMARY PREVENTION OF HEART FAILURE: A SCIENTIFIC STATEMENT FROM THE AMERICAN HEART ASSOCIATION coverClinical reviewsRISK-BASED PRIMARY PREVENTION OF HEART FAILURE: A SCIENTIFIC STATEMENT FROM THE AMERICAN HEART ASSOCIATIONAmerican Heart Association·Cardiology· 2025· 21 pagesThis scientific statement discusses the urgent need for prioritizing primary prevention of heart failure (HF) and outlines key opportunities for implementing a risk-based approach in clinical practice.
FINERENONE AND APPARENT TREATMENT-RESISTANT HYPERTENSION IN HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION coverClinical reviewsFINERENONE AND APPARENT TREATMENT-RESISTANT HYPERTENSION IN HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTIONBrigham and Women’s Hospital and Harvard Medical School; British Heart Foundation Cardiovascular Research Centre, University of Glasgow; National Heart Centre Singapore and Duke-National University of Singapore; University of Milano-Bicocca ASST Papa·Cardiology· 2026· 14 pagesThis research article investigates the effects of finerenone on patients with apparent treatment-resistant hypertension in the context of heart failure with mildly reduced or preserved ejection fraction.
GUIDELINE WATCH ROUNDUP coverClinical reviewsGUIDELINE WATCH ROUNDUPBrigham and Women·Cardiology· 2026· 27 pagesSummaries and highlights of the most important new clinical guidelines to inform your practice.
PreviousPage 11 of 19Next

© 2026 Osler Market

Library·Ask Osler·Learn·Terms·Privacy·Support·WhatsApp Channel

For learning purposes. Always consult clinical guidelines.

Ask OslerLibraryLearn
HomeAskLibraryLearnAccount